Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.jaut.2021.102649 http://scihub22266oqcxt.onion/10.1016/j.jaut.2021.102649 33984571!8088234!33984571     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Autoimmun 2021 ; 121 (ä): 102649 Nephropedia Template TP {{tp|p=33984571|t=2021. A recommended paradigm for vaccination of rheumatic disease patients with the SARS-CoV-2 vaccine |pdf=|usr=}}{{33984571}} gab.com Text A recommended paradigm for vaccination of rheumatic disease patients with the SARS-CoV-2 vaccine JO: J Autoimmun http://www.kidney.de/pget.php?&tw=1&pmid=33984571 #FOAvip Autoimmune and autoinflammatory rheumatic disorders (ARD) are treated with antimetabolites, calcineurin inhibitors and biologic agents either neutralizing cytokines [Tumor Necrosis Factor (TNF), Interleukin (IL)-1, IL-6, IL-17, B-cell activating factor] or being directed against B-cells (anti-CD-20), costimulatory molecules or JAK kinases. Similarly for the influenza or pneumococcal vaccines, there is limited data on the effectiveness of vaccination against SARS-CoV-2 infection and COVID-19 prevention for this susceptible patient population. Moreover, preliminary data from vaccinated organ transplanted, inflammatory bowel and connective tissue disease patients suggests only limited immunogenicity after the first vaccine dose, particularly in patients on immunosuppressive regimens. Herein a set of recommendations for the vaccination of immune suppressed patients with the SARS-CoV-2 vaccines is proposed aimed at achieving optimal vaccine benefit without interfering with disease activity status. Moreover, rare autoimmune adverse events related to vaccinations are discussed. Twit Text FOAVip A recommended paradigm for vaccination of rheumatic disease patients with the SARS-CoV-2 vaccine ????J Autoimmun http://www.kidney.de/pget.php?&tw=1&pmid=33984571 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33984571 #FOAvip English Wikipedia <ref>{{Cite pmid|33984571}}</ref> A recommended paradigm for vaccination of rheumatic disease patients with the SARS-CoV-2 vaccine #MMPMID33984571 Moutsopoulos HM J Autoimmun 2021[Jul]; 121 (ä): 102649 PMID33984571show ga Autoimmune and autoinflammatory rheumatic disorders (ARD) are treated with antimetabolites, calcineurin inhibitors and biologic agents either neutralizing cytokines [Tumor Necrosis Factor (TNF), Interleukin (IL)-1, IL-6, IL-17, B-cell activating factor] or being directed against B-cells (anti-CD-20), costimulatory molecules or JAK kinases. Similarly for the influenza or pneumococcal vaccines, there is limited data on the effectiveness of vaccination against SARS-CoV-2 infection and COVID-19 prevention for this susceptible patient population. Moreover, preliminary data from vaccinated organ transplanted, inflammatory bowel and connective tissue disease patients suggests only limited immunogenicity after the first vaccine dose, particularly in patients on immunosuppressive regimens. Herein a set of recommendations for the vaccination of immune suppressed patients with the SARS-CoV-2 vaccines is proposed aimed at achieving optimal vaccine benefit without interfering with disease activity status. Moreover, rare autoimmune adverse events related to vaccinations are discussed. |*COVID-19 Vaccines/immunology/therapeutic use[MESH] |*COVID-19/immunology/prevention & control[MESH] |*Immunosuppression Therapy[MESH] |*Rheumatic Diseases/immunology/therapy[MESH] |*Vaccination[MESH] |Cytokines/isolation & purification[MESH] |Humans[MESH] |Pneumococcal Vaccines/immunology/therapeutic use[MESH]A recommended paradigm for vaccination of rheumatic disease patients w(epmc).pdf DeepDyve Pubget Overpricing